ResearcherNational Cheng Kung University HospitalActive in the last 2 years

Wen‐Pin Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0863-203X; OpenAlex author ID A5062527318. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer. Co-author DOI 10.1021/acsnano.4c07903 ↗
Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics12080778 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fei‐Ting Hsu · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Chih‐Chia Huang · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Li-Chan Chang · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Tilahun Ayane Debele · 1 shared paper, 2020 · strength 0.15
- Paper Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pa… DOI 10.3390/pharmaceutics12080778 ↗
Yan‐Shen Shan · 1 shared paper, 2020 · strength 0.15
- Paper Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pa… DOI 10.3390/pharmaceutics12080778 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.